Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
20.20Today’s High
21.0052W low
16.2052W High
26.40Open Price
20.20Prev. Close
17.8500Volume
25938.00Value
532507.14Fundamentals
Market Cap
16.70
Price to Earnings
-2.10
Price to Book Value
5.90
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
2.11
Net Profit TTM
-8.04
Cash From Operating Activity
-3.67
Return on Equity %
-284.74
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
87.2
Week
72.7
Month
77.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
20.55
PIVOT
First Resistance
20.93
Second Resistance
21.32
Third Resistance
21.70
First Support
20.16
Second Support
19.78
Third Support
19.39
Relative Strength Index
58.53
Money Flow Index
76.78
MACD
0.52
MACD Signal
0.52
Average True Range
1.11
Average Directional Index
24.75
Rate of Change (21)
18.67
Rate of Change (125)
-10.15
Commodity Channel Index
47.8
Williams %R
-45
BETA
1 Month
0.45
3 Month
0.92
1 Year
0.58
3 Year
0.24
PRICE CHANGE ANALYSIS
↑ 6.04%
1 Week
Low
High
19.35
21.5
↑ 18.67%
1 Month
Low
High
17.25
22.11
↓ -1.77%
3 Months
Low
High
16.5
22.11
↓ -10.54%
6 Months
Low
High
16.2
23.55
↓ -6.47%
1 Year
Low
High
16.2
26.35
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 0.31 | 0.14 | 0.27 | 1.57 | 1.49 | 1.17 | 0.79 | 2.62 | 2.45 | 1.66 | 2.33 | |
| Operating Expenses Qtr | 3.36 | 2.74 | 1.16 | 1.39 | 1.52 | 0.55 | 1.01 | 2.42 | 2.58 | 1.64 | 2.00 | |
| Operating Profit Qtr | -3.22 | -2.60 | -0.90 | 0.19 | -0.06 | 0.61 | -0.23 | 0.20 | -0.29 | 0.01 | 0.29 | |
| EBIDT Qtr Cr | -3.05 | -2.60 | -0.90 | 0.19 | -0.03 | 0.62 | -0.23 | 0.20 | -0.13 | 0.01 | 0.33 | |
| Depreciation Qtr | 0.05 | 0.06 | 0.06 | 0.06 | 0.03 | 0.07 | 0.07 | 0.07 | 0.23 | -0.07 | 0.07 | |
| Net Profit Qtr | -4.14 | -2.79 | -1.12 | 0.02 | -0.18 | 0.46 | 0.08 | -0.43 | -0.45 | -0.09 | 0.05 | |
| Basic EPS Qtr | -5.10 | -3.43 | -1.38 | 0.02 | -0.22 | 0.56 | 0.01 | -0.05 | -0.56 | -0.11 | 0.07 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2.28 | 6.06 | 8.43 | 8.22 | 197.56 | |
| Operating Expenses Annual Cr | 8.65 | 5.50 | 7.85 | 6.92 | 191.68 | |
| Operating Profit Annual | -6.54 | 0.52 | 0.38 | 1.25 | 5.71 | |
| Operating Profit Margin Annual % | -286.10 | 8.59 | 4.51 | 15.15 | 2.89 | |
| Total Expenses Annual Cr | 9.36 | 6.15 | 8.96 | 8.08 | 196.85 | |
| EBIDT Annual Cr | -6.36 | 0.56 | 0.57 | 1.30 | 5.88 | |
| EBIDT Annual margin % | -278.51 | 9.28 | 6.82 | 15.76 | 2.98 | |
| Depreciation | 0.23 | 0.25 | 0.29 | 0.29 | 1.96 | |
| PAT Before ExtraOrdinary Items Annual Cr | -8.04 | -0.09 | -0.40 | 0.95 | -0.56 | |
| Net Profit Annual | -8.04 | -0.09 | -0.40 | 0.95 | -0.56 | |
| Basic EPS Annual | -9.89 | -0.12 | -0.49 | 1.16 | -0.33 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2.82 | 10.86 | 10.96 | 11.36 | 23.82 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 1.73 | 3.35 | 2.14 | 2.02 | 8.87 | |
| Total Current Liabilities Annual Cr | 2.04 | 6.98 | 7.61 | 7.89 | 83.83 | |
| Total Capital Plus Liabilities Annual Cr | 6.59 | 21.20 | 20.70 | 21.27 | 116.52 | |
| Fixed Assets Annual | 0.01 | 14.39 | 14.64 | 14.81 | 22.88 | |
| Total Non Current Assets Annual | 0.25 | 14.66 | 14.96 | 15.14 | 24.11 | |
| Total Current Assets Annual | 6.34 | 6.54 | 5.75 | 6.13 | 92.41 | |
| Total Assets Annual | 6.59 | 21.20 | 20.70 | 21.27 | 116.52 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 6.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -3.67 | -0.25 | 2.15 | 18.03 | 6.23 | |
| Cash from Investing Activity Annual | 11.50 | 0.01 | -0.13 | 0.07 | -3.09 | |
| Cash from Financing Annual Activity | -3.49 | 0.90 | -0.48 | -9.86 | -4.26 | |
| Net Cash Flow Annual | - | 0.66 | 1.55 | 8.25 | -1.12 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 3.47 | 13.36 | 13.47 | 13.96 | 14.06 | |
| ROE Annual % | -284.74 | -0.86 | -3.63 | 8.32 | -2.36 | |
| ROCE Annual % | -144.81 | 2.19 | 2.14 | 7.54 | 12.01 | |
| Total Debt to Total Equity Annual | 0.64 | 0.59 | 0.56 | 0.61 | 0.82 | |
| EBDIT Annual Margin % | -301.38 | 9.34 | 6.97 | 15.85 | 2.97 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| PRABHA RAMESHKUMAR GUPTA | 4.92 | 75279614 |
| RAJESH PODDAR | 4.69 | 75279615 |
| SEEMA AGGARWAL | 2.46 | 75279616 |
| NITIN SHARMA | 1.24 | 75279617 |
| VIVEK AGGARWAL | 1.23 | 75279618 |
| HUF | 2.06 | 75279608 |
| SOHAM TRADING AND INVESTMENTS PVT LTD | 1.22 | 75279611 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 24, 2013 | 0.25 | FINAL | - | Equity Share |
| Sep 24, 2012 | 0.5 | FINAL | - | Equity Share |
| Oct 13, 2011 | 0.5 | FINAL | Oct 15, 2011 | Equity Share |
| Sep 23, 2010 | 0.8 | FINAL | - | Equity Share |
| Sep 23, 2009 | 0.8 | FINAL | - | Equity Share |
| Sep 24, 2008 | 0.8 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 30, 2024 | Audited Results | - |
| Feb 13, 2024 | Quarterly Results | - |
| Nov 14, 2023 | Quarterly Results | - |
| Aug 14, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Aug 13, 2022 | Quarterly Results | - |
| May 30, 2022 | Audited Results | - |
| Feb 14, 2022 | Quarterly Results | - |
| Nov 13, 2021 | Quarterly Results | - |
| Aug 14, 2021 | Quarterly Results | - |
| Jul 09, 2021 | Audited Results | (Revised) |
| Jun 30, 2021 | Audited Results | - |
| Feb 13, 2021 | Quarterly Results | - |
| Jan 23, 2021 | Allotment of equity shares | Inter alia, to consider and approve allotment of shares to the eligible shareholders as on 13.01.2021 (Record date) pursuant to Scheme of Arrangement. |
| Jan 01, 2021 | Others | Inter alia, 1.To take on record the sanction of the said Scheme by Hon'ble NCLT Hyderabad Bench and to declare the scheme effective from April 1, 2020. |
| Nov 13, 2020 | Quarterly Results | - |
| Sep 15, 2020 | Quarterly Results | - |
| Jul 30, 2020 | Audited Results | (Revised) |
| Jun 30, 2020 | Audited Results | - |
| Feb 14, 2020 | Quarterly Results | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 14, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results | - |
| Feb 14, 2019 | Quarterly Results | - |
| Nov 13, 2018 | Quarterly Results | - |
| Aug 14, 2018 | Unaudited Financial Results | - |
| May 30, 2018 | Audited Results | - |
| Feb 13, 2018 | Quarterly Results | - |
| Dec 14, 2017 | Quarterly Results | - |
| Sep 14, 2017 | Quarterly Results | - |
| Aug 31, 2017 | To consider Demerger | Demerger of Undertaking related to API Intermediates Division (Unit - II) of M/s Ortin Laboratories Limited into M/s Vineet Laboratories Limited by way of demerger procedure. |
| May 30, 2017 | Audited Results | - |
| Feb 14, 2017 | Quarterly Results | - |
| Nov 12, 2016 | Quarterly Results | Limited Review Report for the quarter ended September 30, 2016. |
| Aug 29, 2016 | Proposal for Demerger | - |
| Aug 12, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results | - |
| Feb 11, 2016 | Quarterly Results & Others | 1. Appointment of secretarial auditor for the financial year 2015-16.2. The Board has considered the proposal and decided to start OTC Marketing of Products like Cough Syrup, Pain cream. |
| Nov 14, 2015 | Quarterly Results | Change of registered office of the Company within the city limits. |
| Aug 14, 2015 | Quarterly Results | - |
| May 30, 2015 | Audited Results | - |
| Mar 31, 2015 | Appointment of Woman Director & Others | 1. Appointment of CFO. 2.Appointment of Secretarial Auditor. |
| Feb 14, 2015 | Quarterly Results | - |
| Nov 14, 2014 | Quarterly Results | - |
| May 30, 2014 | Audited Results | - |
| Feb 14, 2014 | Quarterly Results | - |
| Nov 14, 2013 | Quarterly Results | - |
| Aug 14, 2013 | Quarterly Results | - |
| May 30, 2013 | Audited Results | - |
| Jan 30, 2013 | Quarterly Results | - |
| Nov 14, 2012 | Quarterly Results | - |
| Aug 29, 2012 | Quarterly Results | (Revised) |
| May 12, 2012 | Quarterly Results | - |
| Jan 31, 2012 | Quarterly Results | - |
| Oct 31, 2011 | Quarterly Results | - |
| Oct 13, 2011 | Allotment of Equity Shares | To allot the Equity Shares to the shareholders of M/s Vineet Laboratories Pvt Ltd on account of merger of M/s Vineet Laboratories Pvt Ltd with M/s Oritin Laboratories Ltd. |
| Jul 30, 2011 | Quarterly Results | - |
| Jun 18, 2011 | To consider the Merger Progress | To consider the followings: 1. The progress in Merger of M/s. Vineet Laboratories Private Ltd. with M/s. Ortin Laboratories Ltd. 2. To acquire stake in M/s. Ortin Biotech Private Ltd. |
| May 14, 2011 | Quarterly Results | - |
| Jan 31, 2011 | Quarterly Results | - |
| Dec 28, 2010 | Scheme of Merger | To consider the followings: 1. Swap Ratio for Amalgamation of Vineet Laboratories Private Limited with Ortin Laboratories Ltd. 2. Scheme of Merger and Amalgamation as said above. |
| Oct 30, 2010 | Quarterly Results | - |
| Sep 30, 2010 | Others | 1. To review the performance of the Company. 2. To review the progress made in the Merger of M/s. Vineeth Laboratories Pvt Ltd with the Company M/s Ortin Laboratories Ltd. |
| Aug 26, 2010 | Allotment of Equity Shares | For allotment of 10,30,000 Equity Shares of Rs. 10 each with a premium of Rs. 8 per Share on conversion of 10,30,000 CW's at an issue price of Rs. 18/- each to the Promoters & Others on pref. basis. |
| Jul 30, 2010 | Quarterly Results | - |
| Jul 21, 2010 | Acquisition of a Co. by way of Merger | The Board has decided to acquire Vineet Laboratories Pvt. Ltd. by way of Merger is an unlisted Co. is located in the State of AP & Engaged in Manufacturing of Fine Chemicals, Custom Synthesis & etc. |
| Jun 14, 2010 | Allotment of Convertible Warrants | The Board has considered and approved the allotment of 15,00,000 Convertible Warrants at an issue price of Rs. 18/- each to the Promoters and Others on preferential basis. |
| Apr 30, 2010 | Quarterly Results | - |
| Apr 17, 2010 | Issue of Equity Share / Warrants | To issue of 15,00,000 Convertible Warrants on preferential basis to the Promoters and the others at an issue price of Rs. 18/- per Warrant & to convene EGM on May 18, 2010 for the same. |
| Jan 30, 2010 | Quarterly Results | - |
| Oct 30, 2009 | Quarterly Results | - |
| Aug 28, 2009 | Audited Results | - |
| Jul 31, 2009 | Quarterly Results | - |
| Apr 30, 2009 | Quarterly Results | - |
| Jan 31, 2009 | Quarterly Results | - |
| Oct 30, 2008 | Quarterly Results | - |
| Jul 25, 2008 | Quarterly Results | - |
| Jan 29, 2008 | Quarterly Results | - |
| Jan 09, 2008 | To consider Issue of securities | inter alia, to consider, the proposal of issue of securities on preferential basis. (Revised) |
| Oct 30, 2007 | Quarterly Results | - |
| Aug 30, 2007 | Audited Results | - |
| Jul 30, 2007 | Quarterly Results | - |
| Apr 30, 2007 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
29 Jun 2024
Ortin Laboratories Ltd - 539287 - Closure of Trading Window
Closure of trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 for the quarter ended 30.06.2024
30 May 2024
Ortin Laboratories Ltd - 539287 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015
30 May 2024
Ortin Laboratories Ltd - 539287 - Audited Financial Results For The Quarter And Financial Year Ended 31.03.2024
Audited financial results for the quarter and financial year ended 31.03.2024
30 May 2024
Ortin Laboratories Ltd - 539287 - Board Meeting Outcome for Outcome Of Board Meeting For The Quarter And Year Ended 31.03.2024 Under Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Outcome of Board Meeting for the quarter and year ended 31.03.2024 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015.
30 May 2024
Ortin Laboratories Ltd - 539287 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31.03.2024
22 May 2024
Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Audited Results For The Quarter And Year Ended 31.03.2024
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve 1. Audited Financial Statements for the quarter and year ended 31.03.2024. 2. Audit Report for the year ended 31.03.2024. 3. Any other business with the permission of the Chair.
20 Apr 2024
Ortin Laboratories Ltd - 539287 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Ortin Laboratories Ltd 2 CIN NO. L24110TG1986PLC006885 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2024-25, FY 2023-24 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2023-24,2022-23 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Divya PurswaniDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Srinivasa Kumar Sanka Designation : -CFO Date: 20/04/2024
17 Apr 2024
Ortin Laboratories Ltd - 539287 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg.74 (5) of SEBI (DP) Regulations ,2018 for the Quarter and year ended 31.03.2024
17 Apr 2024
Ortin Laboratories Ltd - 539287 - Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The FY Ending 31.03.2024
Disclosure under regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements ) Regulations, 2015 for the FY ending 31.03.2024
17 Apr 2024
Ortin Laboratories Ltd - 539287 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31.03.2024.
Compliance certificate under regulation 7(3)of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended 31.03.2024
